The University of Barcelona Science Park reaches a new investment record of €230 million in 2025

by Parc Científic de Barcelona

The University of Barcelona Parc Científic de Barcelona (PCB-UB) broke its investment record in 2025, with a total of €229.7 million raised by the companies in its ecosystem. Start-ups, spin-offs a...

Read more

The IIBB-CSIC and Chemotargets promote the development of new therapies against cancer through the computational design of pharmaceuticals

by Parc Científic de Barcelona

The collaboration combines the IIBB-CSIC’s experience in preclinical oncology models with Chemotargets’ platform for the design and generation of pharmaceuticals in order to facilitate the discove...

Read more

INBRAIN Neuroelectronics completes the first‑in‑human study of its brain–computer interface

by Parc Científic de Barcelona

INBRAIN Neuroelectronics, a neurotechnology company developing graphene-based brain-computer interface therapeutics (BCI-Tx), today announced completion of patient recruitment in its first-in-human st...

Read more

GAT Therapeutics and the University of Barcelona outline a new therapeutic strategy for interstitial lung diseases

by Parc Científic de Barcelona

GTX-11, developed by GAT Therapeutics and protected by patent, is a small oral molecule that modulates the TGFβ signalling pathway, a key factor in fibrotic processes, characterised by the excessive ...

Read more

Aptadel Therapeutics raises 2 million euros and prepares a new round to bring the project to the clinical phase stage

by Parc Científic de Barcelona

​Aptadel Therapeutics​ takes another step forward in the development of its treatment for Ewing’s sarcoma. The biotechnology company has closed a bridge round of 2 million euros with the entry o...

Read more

Pharmacelera and Chemspace drive ultra‑large‑scale 3D virtual screening with a new integrated solution

by Parc Científic de Barcelona

Pharmacelera and Chemspace have announced the launch of a powerful new joint solution that integrates Chemspace Freedom Space 5.0 with Pharmacelera’s flagship virtual screening platform, exaScreen®...

Read more

Promising results for GAT Therapeutics drug in development for pulmonary fibrosis

by Parc Científic de Barcelona

The biotech company GAT Therapeutics is making progress in the development of GTX-11, a new oral drug candidate for the treatment of idiopathic pulmonary fibrosis. Preclinical results show that GTX-11...

Read more

CNAG maps the most complete set of protein domains in human endogenous retroviruses

by Parc Científic de Barcelona

It has been analysed a vast dataset of 120,000 open reading frames (ORFs) derived from human endogenous retroviruses (HERVs) and identified 17,540 retroviral protein domains. The study paves the way f...

Read more

Orikine Bio receives €2.7M in investment from CDTI Innovación together with two other investors

by Parc Científic de Barcelona

The biotechnology company Orikine Bio, recently established at the Barcelona Science Park, has received an investment of €2.7 million from the SICC Innvierte of CDTI Innovación together with the fu...

Read more

The CNAG participates in a study that identifies the first case of spontaneous genetic correction in a severe immunodeficiency linked to the Epstein-Barr virus

by Parc Científic de Barcelona

Researchers from the National Center for Genomic Analysis (CNAG) identifies a case of spontaneous correction of a genetic mutation in a patient with CD137 deficiency, a rare immunodeficiency that caus...

Read more

IBMB-CSIC strengthens its scientific capacity with the creation of a new platform specialized in Mitochondria and Metabolism

by Parc Científic de Barcelona

This new platform aims to support both internal and external researchers in the study of cellular metabolism, a key field for understanding fundamental processes such as ageing, metabolic diseases, ca...

Read more

CNAG publishes the first cellular atlas of inflammation that uses artificial intelligence to accelerate the diagnosis of inflammatory diseases

by Parc Científic de Barcelona

Researchers from the National Center for Genomic Analysis (CNAG) have published the first cellular atlas of inflammation, a comprehensive database that analysed more than 6.5 million blood cells from ...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Fat-associated liver disease plays a key...

by Fundació Clínic per a la Recerca Biomèdica

Researchers from Clínic-IDIBAPS have participated in a study publishe...

Photos Stream